{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:59:08Z","timestamp":1781765948574,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.biopha.2022.112710","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T06:58:01Z","timestamp":1645685881000},"page":"112710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Randomized trial of topical ascorbic acid in DMSO versus imiquimod for the treatment of basal cell carcinoma"],"prefix":"10.1016","volume":"148","author":[{"given":"Briant","family":"Burke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon-Eric","family":"Bailie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.112710_bib1","unstructured":"American Cancer Society. Cancer Facts and Figures 2019. Cancer.org. \u3008fhttps:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/cancer-acts-figures-2019.html\u3009 (accessed 12 July 2021)."},{"issue":"10","key":"10.1016\/j.biopha.2022.112710_bib2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","article-title":"Incidence estimate of non-melanoma skin cancer (keratinocyte carcinomas) in the US population, 2012","volume":"151","author":"Rogers","year":"2015","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.biopha.2022.112710_bib3","unstructured":"American Cancer Society. Basal and squamous skin cancers. Cancer.org. \u3008http:\/\/www.cancer.org\/cancer\/skincancer-basalandsquamouscell\/detailedguide\/skin-cancer-basal-and-squamous-cell-what-is-basal-and-squamous-cell\u3009 (accessed 23 July 2021)."},{"issue":"2","key":"10.1016\/j.biopha.2022.112710_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amepre.2014.08.036","article-title":"Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011","volume":"48","author":"Guy","year":"2015","journal-title":"Am. J. Prev. Med."},{"issue":"5","key":"10.1016\/j.biopha.2022.112710_bib5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/DSS.0000000000000296","article-title":"Consensus for non-melanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods","volume":"41","author":"Kauvar","year":"2015","journal-title":"Dermatol. Surg."},{"issue":"2","key":"10.1016\/j.biopha.2022.112710_bib6","first-page":"86","article-title":"Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma","volume":"21","author":"Schulstad","year":"2009","journal-title":"Dermatol. Nurs."},{"issue":"9","key":"10.1016\/j.biopha.2022.112710_bib7","first-page":"910","article-title":"Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage","volume":"6","author":"Neville","year":"2007","journal-title":"J. Drugs Dermatol."},{"issue":"3","key":"10.1016\/j.biopha.2022.112710_bib8","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00042728-200503000-00012","article-title":"Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial","volume":"31","author":"Peris","year":"2005","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.biopha.2022.112710_bib9","first-page":"1165","article-title":"Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: a comparison of dosing regimens","volume":"138","author":"Shumack","year":"2002"},{"issue":"5","key":"10.1016\/j.biopha.2022.112710_bib10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/1203475420931770","article-title":"Topical imiquimod as a treatment option for nodular basal cell carcinoma: a systematic review","volume":"24","author":"Huang","year":"2020","journal-title":"J. Cutan. Med Surg."},{"issue":"1","key":"10.1016\/j.biopha.2022.112710_bib11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1470-2045(13)70530-8","article-title":"Surgical excision versus 5% imiquimod cream for nodular and superficial basal cell carcinoma (SINS): a multicentre, non-inferiority, randomized controlled trial","volume":"15","author":"Bath-Hextall","year":"2014","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2022.112710_bib12","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archderm.143.2.266","article-title":"Fifty-five basal cell carcinomas treated with 5% Imiquimod: outcome at 5 year follow up","volume":"143","author":"Vidal","year":"2007","journal-title":"Arch. Derm."},{"key":"10.1016\/j.biopha.2022.112710_bib13","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.freeradbiomed.2011.03.030","article-title":"Comment on \u201cPharmacologic ascorbate synergizes with Gemcitabine in pre-clinical models of pancreatic cancer\u201d i.e. All we are saying is, give C a chance","volume":"50","author":"Cullen","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2022.112710_bib14","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.freeradbiomed.2011.03.007","article-title":"Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer","volume":"50","author":"Espey","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2022.112710_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.semradonc.2018.10.006","article-title":"Pharmacological ascorbate as a means of sensitizing cancer cells to radio-chemotherapy while protecting normal tissue","volume":"29","author":"Schoenfeld","year":"2019","journal-title":"Semin Radiat. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2022.112710_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41568-019-0135-7","article-title":"Targeting cancer vulnerabilities with high dose vitamin C","volume":"19","author":"Ngo","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2022.112710_bib17","article-title":"Treatment of facial basal cell carcinoma: a review","volume":"vol. 2011","author":"Smith","year":"2011","journal-title":"J. Ski. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2022.112710_bib18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.5114\/ada.2019.83027","article-title":"Efficiency of long-term high-dose intravenous ascorbic acid therapy in locally advanced basal cell carcinoma \u2013 a pilot study","volume":"39","author":"B\u00e1nv\u00f6lgyi","year":"2020","journal-title":"Post. Dermatol. Alergol."},{"issue":"6266","key":"10.1016\/j.biopha.2022.112710_bib19","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1126\/science.aaa5004","article-title":"Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH","volume":"350","author":"Yun","year":"2015","journal-title":"Science"},{"issue":"32","key":"10.1016\/j.biopha.2022.112710_bib20","doi-asserted-by":"crossref","first-page":"11105","DOI":"10.1073\/pnas.0804226105","article-title":"Pharmacologic doses of ascorbate act as a pro-oxidant and decrease growth of aggressive tumor xenografts in mice","volume":"105","author":"Chen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.112710_bib21","unstructured":"Vitamin C. \u3008http:\/\/sites.science.oregonstate.edu\/chemistry\/courses\/ch130\/old\/VITCTEXT.htm\u3009 (accessed 12 Jan 2022)."},{"issue":"1","key":"10.1016\/j.biopha.2022.112710_bib22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jaad.2016.04.003","article-title":"Topically applied ascorbic acid solution for the treatment of basal cell carcinoma (BCC)","volume":"75","author":"Holl\u00f3","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2022.112710_bib23","first-page":"61","article-title":"Dimethyl sulfoxide (DMSO): a review","volume":"76","author":"Brayton","year":"1986","journal-title":"Cornell Vet."},{"issue":"3","key":"10.1016\/j.biopha.2022.112710_bib24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1200\/JCO.1984.2.3.227","article-title":"Polar solvents: a novel class of antineoplastic agents","volume":"2","author":"Spremulli","year":"1984","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.biopha.2022.112710_bib25","first-page":"24","article-title":"Dimethyl sulfoxide: history, chemistry, and clinical utility in dermatology","volume":"5","author":"Capriotti","year":"2012","journal-title":"J. Clin. Aesthet. Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2022.112710_bib26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1468-3083.2008.02946.x","article-title":"Photodynamic therapy with. 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up","volume":"23","author":"Christensen","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"3\u20134","key":"10.1016\/j.biopha.2022.112710_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pdpdt.2009.09.001","article-title":"Long-term follow-up of topical 5-aminolaevulinic acid photodynamic therapy diode laser single session for non-melanoma skin cancer","volume":"6","author":"Souza","year":"2009","journal-title":"Photo Photo Ther."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222000981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222000981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:35:56Z","timestamp":1781764556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222000981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":27,"alternative-id":["S0753332222000981"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112710","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized trial of topical ascorbic acid in DMSO versus imiquimod for the treatment of basal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112710"}}